Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
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
hyKWaJt76Q8tteEy
